These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25458540)

  • 1. Computational studies to predict or explain G protein coupled receptor polypharmacology.
    Jacobson KA; Costanzi S; Paoletta S
    Trends Pharmacol Sci; 2014 Dec; 35(12):658-63. PubMed ID: 25458540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing selective polypharmacology of antipsychotic drugs targeting the bioaminergic receptors through receptor dynamic conformational ensembles.
    Selvam B; Porter SL; Tikhonova IG
    J Chem Inf Model; 2013 Jul; 53(7):1761-74. PubMed ID: 23789628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Diversity in the G Protein-Coupled Receptor Superfamily.
    Vass M; Kooistra AJ; Yang D; Stevens RC; Wang MW; de Graaf C
    Trends Pharmacol Sci; 2018 May; 39(5):494-512. PubMed ID: 29576399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.
    Jacobson KA; Costanzi S
    Mol Pharmacol; 2012 Sep; 82(3):361-71. PubMed ID: 22695719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT1A and 5-HT6 Receptors.
    Gamo AM; González-Vera JA; Rueda-Zubiaurre A; Alonso D; Vázquez-Villa H; Martín-Couce L; Palomares Ó; López JA; Martín-Fontecha M; Benhamú B; López-Rodríguez ML; Ortega-Gutiérrez S
    Chemistry; 2016 Jan; 22(4):1313-21. PubMed ID: 26560738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
    Ciancetta A; Jacobson KA
    Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners.
    Paoletta S; Tosh DK; Salvemini D; Jacobson KA
    PLoS One; 2014; 9(5):e97858. PubMed ID: 24859150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Molecular Pharmacologist's Guide to G Protein-Coupled Receptor Crystallography.
    Piscitelli CL; Kean J; de Graaf C; Deupi X
    Mol Pharmacol; 2015 Sep; 88(3):536-51. PubMed ID: 26152196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New paradigms in GPCR drug discovery.
    Jacobson KA
    Biochem Pharmacol; 2015 Dec; 98(4):541-55. PubMed ID: 26265138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y; Basith S; Choi S
    J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G Protein-Coupled Receptors: target-based in silico screening.
    Senderowitz H; Marantz Y
    Curr Pharm Des; 2009; 15(35):4049-68. PubMed ID: 20028321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
    Rodríguez D; Gutiérrez-de-Terán H
    Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.